Biotech firm Cerenis to double space in A2
As Cerenis Theraputics SA moves ahead with its development of a new cholesterol drug, it has expanded its Ann Arbor space from 2,100 to 4,400 square feet.
As Cerenis Theraputics SA moves ahead with its development of a new cholesterol drug, it has expanded its Ann Arbor space from 2,100 to 4,400 square feet.
Excerpt:
[Mary Campbell, general partner and founder of EDF Ventures, an Ann Arbor venture capital firm that has invested in Cerenis, said,]
“There’s no such thing as a perfect deal, as they say, but this sure comes awfully close to perfection and I’m thrilled that they are in a position to do some expanding here. It’s exactly what Michigan needs.”
The company currently has six employees in Ann Arbor and seven in France.
Related Articles
Free Wonderschool platform will help Michigan families find childcare faster
Scheduled to launch early 2027, the platform will connect parents to available childcare and preschool spaces with one application.
Partner Partner Content Creativity and community come together at Farmington’s new Art Park Promenade
Farmington’s Art Park Promenade connects Riley Park with the Hillside Townes development through a pedestrian-friendly space filled with landscaping, seating, and public art.
Small Business Social Hours foster success through face-to-face connection
Why face-to-face networking opportunities are even more important for small businesses and entrepreneurs.
